| Patricia Guzman Rojas, MD | |
|
204 Bridgeway St, Aurora, IN 47001-1334 | |
| (812) 926-3133 | |
| (812) 926-1668 |
| Full Name | Patricia Guzman Rojas |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 11 Years |
| Location | 204 Bridgeway St, Aurora, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164874160 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 52678 (Kentucky) | Secondary |
| 207R00000X | Internal Medicine | 52678 (Kentucky) | Secondary |
| 207R00000X | Internal Medicine | 01091629A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Elizabeth Edgewood | Edgewood, KY | Hospital |
| Jewish Hospital & St Mary's Healthcare | Louisville, KY | Hospital |
| Dearborn County Hospital | Lawrenceburg, IN | Hospital |
| University Of Louisville Hospital | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Health Centers, Inc. | 6901700053 | 49 |
| Family Health Centers, Inc. | 6901700053 | 49 |
| Summit Medical Group, Inc | 2163326240 | 693 |
News Archive
Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that it has received a 2.4M Euro grant from the European Commission as part of the Horizon 2020 European Union Framework Programme for Research and Innovation, enabling the company to carry out a large-scale clinical trial in breast cancer.
The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self- administered by the patient monthly.
Twenty years of mortality data from counties across the United States led to the striking discovery that living at higher altitudes may be a risk factor for suicide, according to a provocative study published online ahead of print in High Altitude Medicine & Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc. The article is attached.
Some studies on the genetic roots of aging will need a second look after the discovery that a common lab chemical can extend the life span of female fruit flies by 68 percent.
› Verified 2 days ago
| Entity Name | Family Health Centers, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649732603 PECOS PAC ID: 6901700053 Enrollment ID: O20031121000045 |
News Archive
Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that it has received a 2.4M Euro grant from the European Commission as part of the Horizon 2020 European Union Framework Programme for Research and Innovation, enabling the company to carry out a large-scale clinical trial in breast cancer.
The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self- administered by the patient monthly.
Twenty years of mortality data from counties across the United States led to the striking discovery that living at higher altitudes may be a risk factor for suicide, according to a provocative study published online ahead of print in High Altitude Medicine & Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc. The article is attached.
Some studies on the genetic roots of aging will need a second look after the discovery that a common lab chemical can extend the life span of female fruit flies by 68 percent.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Guzman Rojas, MD Po Box 635283, Cincinnati, OH 45263-5283 Ph: (812) 926-3133 | Patricia Guzman Rojas, MD 204 Bridgeway St, Aurora, IN 47001-1334 Ph: (812) 926-3133 |
News Archive
Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that it has received a 2.4M Euro grant from the European Commission as part of the Horizon 2020 European Union Framework Programme for Research and Innovation, enabling the company to carry out a large-scale clinical trial in breast cancer.
The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self- administered by the patient monthly.
Twenty years of mortality data from counties across the United States led to the striking discovery that living at higher altitudes may be a risk factor for suicide, according to a provocative study published online ahead of print in High Altitude Medicine & Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc. The article is attached.
Some studies on the genetic roots of aging will need a second look after the discovery that a common lab chemical can extend the life span of female fruit flies by 68 percent.
› Verified 2 days ago
Dr. Patricia Freidel, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 107 Bridgeway St, Aurora, IN 47001 Phone: 812-496-8785 Fax: 812-926-0431 |